Publications by authors named "Areej Aljehani"
Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetic disorder associated with an elevated risk of life-threatening arrhythmias and progressive ventricular impairment. Risk stratification is essential to prevent major adverse cardiac events (MACE). Our study aimed to investigate the incremental value of strain measured by two-dimensional speckle-tracking echocardiography in predicting MACE in ARVC patients compared to conventional echocardiographic parameters.
View Article and Find Full Text PDFArrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare inherited disease characterised by early arrhythmias and structural changes. Still, there are limited echocardiography data on its structural progression. We studied structural progression and its impact on the occurrence of major adverse cardiovascular events (MACE).
View Article and Find Full Text PDFArticle Synopsis
- Androgenic anabolic steroids (AAS) are largely misused by young men and are linked to earlier and more serious heart issues, especially regarding the atria.
- Patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) tend to show increased atrial arrhythmias and changes in P waves, indicating a male predisposition to these conditions.
- Experiments on male mice revealed that exposure to the steroid 5α-dihydrotestosterone (DHT) exacerbates cardiac issues, particularly in those with a genetic makeup that reduces plakoglobin, leading to significant electrical remodeling in the heart.